Pengcheng Gu

567 citations
19 papers · 414 indexed · h-index 12
Topics
MicroRNA in disease regulation (4 papers)Shoulder Injury and Treatment (3 papers)Circular RNAs in diseases (3 papers)
Partner nations
ChinaIndiaAfghanistan

In The Last Decade

Pengcheng Gu

19 papers receiving 408 citations

Peers

Pengcheng Gu
Comparison fields: 5 of 64
  • Surgery 169
  • Molecular Biology 142
  • Cancer Research 127
  • Orthopedics and Sports Medicine 82
  • Pathology and Forensic Medicine 44
Replace Taotao Xu with:
Taotao Xu China
Ke Jiang China
Angelika K. Lemke Germany
Qiankun Zhang China
Tieyi Yang China
Nobuaki Chinzei Japan
Wenxi Du China
Nisha Sambamurthy United States
Pengcheng Gu relative to Taotao Xu China Taotao Xu's profile →
Citations per field
00.5×5.7×
Taotao Xu · 1×
Citations per year

Countries citing papers authored by Pengcheng Gu

Since Specialization
Citations

This map shows the geographic impact of Pengcheng Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengcheng Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengcheng Gu more than expected).

Fields of papers citing papers by Pengcheng Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pengcheng Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengcheng Gu. The network helps show where Pengcheng Gu may publish in the future.

Co-authorship network of co-authors of Pengcheng Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Pengcheng Gu. A scholar is included among the top collaborators of Pengcheng Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pengcheng Gu. Pengcheng Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 19
2 4
3 18
4 54
5 15
6 2
7 43
8 15
9 11
10 101
11
Perineural invasion: a potential reason of hepatocellular carcinoma bone metastasis.
10
12 15
13 1
14 20
15 59
16 17
17 8
18 1
19 1

About Pengcheng Gu

Pengcheng Gu is a scholar working on Complementary and alternative medicine, Cancer Research and Orthopedics and Sports Medicine, having authored 19 papers that have together received 414 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Shoulder Injury and Treatment (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Orthopedics and Sports Medicine (82 citations), Cancer Research (127 citations) and Surgery (169 citations). Pengcheng Gu has collaborated with scholars based in China, India and Afghanistan. Frequent co-authors include Xiangjin Lin, Sanzhong Xu, Tong Xiang, Youzhi Cai, Chi Zhang, Yijun Zhang, Tianjiao Wang, Shuo Wang, Tong Shen and Xigong Li. Their work appears in journals such as PLoS ONE, The American Journal of Sports Medicine and Clinical Orthopaedics and Related Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026